| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $108.3M | -4.4% |
| R&D Expense | $159.7M | +22.8% |
| SG&A Expense | $59.0M | +15.1% |
| Operating Income | -$110.4M | -62.4% |
| Pre-tax Income | -$97.0M | -66.7% |
| Income Tax | -$677K | +0.0% |
| Net Income | -$97.0M | -68.7% |
| EPS (Basic) | -$0.70 | -29.6% |
| EPS (Diluted) | -$0.70 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $302.1M | +50.8% |
| Accounts Receivable | $1.4M | -93.3% |
| Current Assets | $320.4M | +36.1% |
| Total Assets | $352.2M | +28.1% |
| Current Liabilities | $111.0M | -40.5% |
| Total Liabilities | $134.8M | -40.7% |
| Stockholders' Equity | $209.5M | +428.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$151.0M | -677.2% |
| Capital Expenditures | $938K | -15.9% |
| Investing Cash Flow | -$938K | +15.9% |
| Financing Cash Flow | $253.9M | +91.6% |
| Free Cash Flow | -$152.0M | -639.6% |
| -29.6% |